TTP399

Enroll Now

Type of Study:

Study Assessing the Safety, and Tolerability of TTP399 in Adult Patients Type 1 Diabetes

Title of Study:

This study will compare TTP399 to placebo

Short Title:

TTP399

Study Length: 5 months

Target Age/Sex: 18 – 70 years of age, Male and Female

Benefits:

Participants will receive at no cost: study product, study materials and study-specific procedures

Link: ClinicalTrials.gov